COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00966251
Recruitment Status : Terminated (The study was stopped because of slow accrual)
First Posted : August 26, 2009
Last Update Posted : October 23, 2012
Teva Pharmaceutical Industries
Information provided by (Responsible Party):
CureTech Ltd

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011